Literature DB >> 8161626

Serum levels of interleukin-1 alpha, interleukin-1 beta, interleukin-6, and tumor necrosis factor in patients with acute viral hepatitis.

D Torre1, C Zeroli, M Giola, G Ferrario, G P Fiori, G Bonetta, R Tambini.   

Abstract

Serum levels of interleukin-1 alpha (IL-1 alpha), interleukin-1 beta (IL-1 beta), interleukin-6 (IL-6), and tumor necrosis factor-alpha (TNF-alpha) in patients with acute viral hepatitis were investigated. Twelve patients suffering from acute viral hepatitis were studied; 8 patients presented with acute hepatitis B, 2 patients with acute hepatitis A, and 2 patients with acute hepatitis C. Serum levels of IL-1 alpha, IL-1 beta, IL-6, and TNF-alpha were significantly increased in all patients with acute viral hepatitis. Decreased serum levels of all cytokines were noted in four patients with acute hepatitis B during the recovery phase of infection. In addition, IL-1 alpha, IL-1 beta, IL-6, and TNF-alpha were undetectable at the end of a follow-up period of 6 months. Our study shows that increased levels of IL-1 alpha, IL-1 beta, IL-6, and TNF-alpha are probably related to hepatitis activity and thus may have some role in hepatocytic injury.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8161626     DOI: 10.1093/clinids/18.2.194

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  20 in total

1.  Reactive peripheral blood plasmacytosis in a patient with acute hepatitis A.

Authors:  Taizo Wada; Hideaki Maeba; Yasuhiro Ikawa; Yoko Hashida; Akiko Okumura; Fumie Shibata; Yumi Tone; Masayuki Inoue; Shoichi Koizumi; Hajime Takatori; Yoshio Sakai; Shuichi Kaneko; Akihiro Yachie
Journal:  Int J Hematol       Date:  2007-04       Impact factor: 2.490

Review 2.  Hepatitis C virus infection and type 1 and type 2 diabetes mellitus.

Authors:  Alessandro Antonelli; Silvia Martina Ferrari; Dilia Giuggioli; Andrea Di Domenicantonio; Ilaria Ruffilli; Alda Corrado; Silvia Fabiani; Santino Marchi; Clodoveo Ferri; Ele Ferrannini; Poupak Fallahi
Journal:  World J Diabetes       Date:  2014-10-15

3.  Late interleukin-6 escalates T follicular helper cell responses and controls a chronic viral infection.

Authors:  James A Harker; Gavin M Lewis; Lauren Mack; Elina I Zuniga
Journal:  Science       Date:  2011-09-29       Impact factor: 47.728

4.  Increased levels of soluble adhesion molecules in the serum of patients with hepatitis C. Correlation with cytokine concentrations and liver inflammation and fibrosis.

Authors:  G Kaplanski; C Farnarier; M J Payan; P Bongrand; J M Durand
Journal:  Dig Dis Sci       Date:  1997-11       Impact factor: 3.199

5.  Serum vascular endothelial growth factor levels in various liver diseases.

Authors:  F Akiyoshi; M Sata; H Suzuki; Y Uchimura; K Mitsuyama; K Matsuo; K Tanikawa
Journal:  Dig Dis Sci       Date:  1998-01       Impact factor: 3.199

6.  Hepatitis C virus core protein inhibits tumor necrosis factor alpha-mediated apoptosis by a protective effect involving cellular FLICE inhibitory protein.

Authors:  Kousuke Saito; Keith Meyer; Rebecca Warner; Arnab Basu; Ratna B Ray; Ranjit Ray
Journal:  J Virol       Date:  2006-05       Impact factor: 5.103

Review 7.  Safety of antitumour necrosis factor (anti-TNF) therapy in patients with chronic viral infections: hepatitis C, hepatitis B, and HIV infection.

Authors:  L H Calabrese; N Zein; D Vassilopoulos
Journal:  Ann Rheum Dis       Date:  2004-11       Impact factor: 19.103

Review 8.  TNFalpha blockade in human diseases: mechanisms and future directions.

Authors:  Maida Wong; David Ziring; Yael Korin; Sheetal Desai; Sungjin Kim; Jan Lin; David Gjertson; Jonathan Braun; Elaine Reed; Ram Raj Singh
Journal:  Clin Immunol       Date:  2007-10-03       Impact factor: 3.969

9.  mRNA cytokine profile in peripheral blood cells from chronic hepatitis C virus (HCV)-infected patients: effects of interferon-alpha (IFN-alpha) treatment.

Authors:  S Shapiro; V Gershtein; N Elias; E Zuckerman; N Salman; N Lahat
Journal:  Clin Exp Immunol       Date:  1998-10       Impact factor: 4.330

10.  Tumor Necrosis Factor Inhibits Spread of Hepatitis C Virus Among Liver Cells, Independent From Interferons.

Authors:  Stephen M Laidlaw; Svetlana Marukian; Rachel H Gilmore; Siobhán B Cashman; Volodymyr Nechyporuk-Zloy; Charles M Rice; Lynn B Dustin
Journal:  Gastroenterology       Date:  2017-04-26       Impact factor: 22.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.